Clinical trial
First In Man Evaluation of the Vesta™ & VestaCOR™ (Hydroxy-Apetite Coated genX™) Stent for Treatment of de Novo Native Coronary Artery Lesion(s)
NCT00474084 is registered in ClinicalTrials.gov with BioSync Scientific Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First In Man Evaluation of the Vesta™ & VestaCOR™ (Hydroxy-Apetite Coated genX™) Stent for Treatment of de Novo Native Coronary Artery Lesion(s)
- Lead sponsor
- BioSync Scientific Pvt. Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2007
- Completion date
- Not reported
- Enrollment
- 70 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.